We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
» New Parkinson’s Drug Shows Promise
New Parkinson’s Drug Shows Promise
October 21, 2013
Impax Pharmaceuticals’ Parkinson’s disease candidate IPX066 appears to benefit patients just beginning their journeys with the disease.
Medpage Today
Upcoming Events
15
Apr
Five Telltale Signs You’re Ready for an Electronic TMF System
21
Apr
CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health
26
Apr
MAGI's Clinical Research vConference — Spring 2021
06
May
The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Roche Receives CE Mark for Elecsys Cancer Test
Biogen and Bio-Thera Solutions Partner Over Actemra Biosimilar
Former Indivor Executive Seeks FDA Hearing to Avoid Debarment
FDA Clears Activ Surgical’s Imaging Module for ActivEdge Platform
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
